These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12883492)

  • 1. Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival.
    Schmitt-Gräff A; Ertelt V; Allgaier HP; Koelble K; Olschewski M; Nitschke R; Bochaton-Piallat ML; Gabbiani G; Blum HE
    Hepatology; 2003 Aug; 38(2):470-80. PubMed ID: 12883492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival.
    Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K
    Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
    Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
    J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma.
    Shibata T; Chuma M; Kokubu A; Sakamoto M; Hirohashi S
    Hepatology; 2003 Jul; 38(1):178-86. PubMed ID: 12830000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
    Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
    Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
    Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
    Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ki67+ proliferation index correlates with increased cellular retinol-binding protein-1 and the coordinated loss of plakophilin-1 and desmoplakin during progression of cervical squamous lesions.
    Schmitt-Graeff A; Koeninger A; Olschewski M; Haxelmans S; Nitschke R; Bochaton-Piallat ML; Lifschitz-Mercer B; Gabbiani G; Langbein L; Czernobilsky B
    Histopathology; 2007 Jul; 51(1):87-97. PubMed ID: 17593084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing.
    Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO
    Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
    Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
    Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular retinol-binding protein-1 expression in normal and fibrotic/cirrhotic human liver: different patterns of expression in hepatic stellate cells and (myo)fibroblast subpopulations.
    Lepreux S; Bioulac-Sage P; Gabbiani G; Sapin V; Housset C; Rosenbaum J; Balabaud C; Desmoulière A
    J Hepatol; 2004 May; 40(5):774-80. PubMed ID: 15094224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
    Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
    Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.
    Chung GG; Provost E; Kielhorn EP; Charette LA; Smith BL; Rimm DL
    Clin Cancer Res; 2001 Dec; 7(12):4013-20. PubMed ID: 11751495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
    Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
    Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
    Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
    J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.
    Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T
    Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.